Moolec Science Stock (NASDAQ:MLEC)


OwnershipChart

Previous Close

$7.17

52W Range

$3.08 - $120.00

50D Avg

$8.05

200D Avg

$9.60

Market Cap

$5.26M

Avg Vol (3M)

$262.52K

Beta

0.27

Div Yield

-

MLEC Company Profile


Moolec Science S.A. is an innovative biotechnology firm specializing in the development of plant-grown animal proteins. Leveraging a transformative method called Molecular Farming, the company is poised to disrupt the alternative protein market. Their product lines and research and development efforts capitalize on the inherent agricultural benefits of select host crops, such as soybeans and peas. Globally, Moolec maintains operations across the United States, Europe, and South America. Established in 2008, the company is headquartered in Luxembourg.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

LU

Employees

52

IPO Date

Mar 02, 2021

Website

MLEC Performance


Latest Earnings Call Transcripts


Q4 24Oct 02, 24 | 8:30 AM
Q3 24May 30, 24 | 8:30 AM
Q1 24Dec 14, 23 | 8:30 AM

Peer Comparison


TickerCompany
NCELNewcelX Ltd.
WINTWindtree Therapeutics, Inc.
VRAXVirax Biolabs Group Limited
XRTXXORTX Therapeutics Inc.
GTBPGT Biopharma, Inc.
TIVCTivic Health Systems, Inc.
DRMADermata Therapeutics, Inc.
GLMDGalmed Pharmaceuticals Ltd.
ELABPMGC Holdings Inc.